South Koreas Deputy PM Warns AI Wealth Must Be Shared Amid Samsung Labor Disputes Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds RussiaUkraine Conflict Escalates Putin Threatens Retaliation After Drone Unit Strike Internal Disputes Threaten HighEnd Survivalist Communitys Business Model SpaceX and OpenAI MegaIPOs Raise Market Top Concerns Analysts Suggest Federal Reserve Dissenters Explain Votes Against Statement Hinting at Next Rate Cut OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline BNGO Q1 2026 Earnings Narrowing Losses Beat Estimates but Stock Declines on Uncertain Outlook Beneficient BENF Q1 2026 Earnings Stellar EPS Surprise Amid Revenue Discretion Highlights Financial Resilience Leslies Inc Q1 2026 Earnings Significant EPS Miss Despite Strong Stock Rally UTStarcom Holdings Corp UTSI Q4 2019 Earnings WiderthanExpected Loss Sends Shares Lower AMBR Q4 2025 Earnings EPS Misses Estimates by Narrow Margin Shares Decline Giftify Inc GIFT Edges Higher as Shares Test Key Resistance Level Textron Inc TXT Edges Higher Amid Defense Sector Strength PureCycle Technologies Warrant PCTTW Holds Steady Near Support Consolidation Phase Stellar SVCCW Stock Analysis No Movement at 020 What It Means 20260527 High Roller Technologies ROLR Gains 269 as Stock Bounces from Support Seven Hills Realty Trust SEVN Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Quarter and Slight Stock Decline Guardian Pharmacy Services Q1 2026 Earnings EPS Misses Estimates Amid Modest Market Response Cerus Corporation Q1 2026 Earnings Narrowing Loss Beats Estimates Amid Operational Progress PagSeguro Digital Ltd PAGS Q1 2026 Earnings Narrow EPS Miss as Costs Offset Revenue Growth SANUWAVE Health Q1 2026 Earnings EPS Misses Estimates by 2838 Revenue Not Disclosed Knowles Corporation KN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Over 4 Ella Langley Achieves Historic Billboard Hot 100 Milestone for Country Music PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances Chemours CC Holds Near Support Amid Modest Decline